Company: CERO
Filing Date: 2025-08-22
Form Type: 10-Q
Source: 0001213900-25-079898
Chunk: 522

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-08-22
Form: 10-Q
Item: Part II, Item 2
Chunk 522
---
 4.8 to the Registration Statement on Form S-1/A filed by CERo Therapeutics
    Holdings, Inc. with the Securities and Exchange Commission on January 21, 2025).

    4.3
     
    Description
    of Securities (incorporated by reference to Exhibit 4.4 to the Current Report on Form S-1 filed by CERo Therapeutics Holdings, Inc.
    with the Securities and Exchange Commission on July 21, 2025).

    10.1+†
     
    Securities
    Purchase Agreement, dated as of April 21, 2025, by and between CERo Therapeutics Holdings, Inc. and the investors named therein (incorporated
    by reference to Exhibit 10.1 to the Current Report on Form 8-K filed by CERo Therapeutics Holdings, Inc. with the Securities and
    Exchange Commission on April 22, 2025).

    10.2+
     
    Form
    of Registration Rights Agreement by and between CERo Therapeutics Holdings, Inc. and the investors signatory thereto (incorporated
    by reference to Exhibit 10.2 to the Current Report on Form 8-K filed by CERo Therapeutics Holdings, Inc. with the Securities and
    Exchange Commission on April 22, 2025).

    10.3
     
    Form
    of Consent Agreement (incorporated by reference to Exhibit 10.3 to the Current Report on Form 8-K filed by CERo Therapeutics Holdings,
    Inc. with the Securities and Exchange Commission on April 22, 2025).

    10.4†
     
    Form
    of Amendment to the Securities Purchase Agreement (incorporated by reference to Exhibit 10.2 to the Current Report on Form 8-K filed
    by CERo Therapeutics Holdings, Inc. with the Securities and Exchange Commission on June 30, 2025).

    10.5^
     
    Employment
    Agreement by and between CERo Therapeutics Holdings, Inc., and Chris Ehrlich, dated May 30, 2025 (incorporated by reference to Exhibit
    10.1 to the Current Report on Form 8-K filed by CERo Therapeutics Holdings, Inc. with the Securities and Exchange Commission on June
    2, 2025).

    10